Back to search results

Evaluating ChatGPT for Gastrointestinal Cancer Treatment Plans

This study is looking at how a computer program called ChatGPT might help doctors create treatment plans for people with gastrointestinal cancers (cancers of the stomach or colon). Researchers want to see if ChatGPT's suggestions influence the treatment plans doctors make. You could be eligible if you are 18 or older, have been diagnosed with gastrointestinal cancer, and have detailed medical records available. The main goal is to see how much ChatGPT changes the treatment plans doctors recommend, with this measured within 24 hours of the plan being decided. The study is currently recruiting participants.

Study design
This study plans to enroll 400 participants with gastrointestinal cancers. You would be randomly assigned to either a group where doctors make treatment plans on their own, or a group where doctors use ChatGPT's suggestions along with their own expertise.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The main outcome of the study is measured within 24 hours after your treatment plan is decided.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06002425

Treatment Recommendations for Gastrointestinal Cancers Via Large Language Models

Recruiting
NAAges 18+InterventionalTreatment
Chinese Academy of Sciences
~400 participants
Updated 2023-09-08 on ClinicalTrials.gov
What's tested:Clinician-Directed Treatment PlanChatGPT-Assisted Treatment Plan

At a glance

Recruiting sites
4 of 7 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Influence Rate of ChatGPT on Treatment Plans
Measured over Within 24 hours after the treatment plan is determined from the onset of study participation.

Conditions

Gastrointestinal Neoplasm Malignant

Explore related trials

Colorectal CarcinomaGastric CarcinomaMalignant Digestive System Neoplasm

Where it's being run

7 sites across 5 states
Guangdong3
California1
Inner Mongolia1
Saxony-Anhalt1
Italy1

Study leadership

  • Di Dong, PhD · PRINCIPAL_INVESTIGATOR · Institute of Automation, Chinese Academy of Sciences

Who to contact

Di Dong, PhD
[email protected]
+86 13811833760
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Age ≥18 years, both male and female.
Pathologically confirmed diagnosis of gastrointestinal cancer (gastric cancer or colorectal Cancer).
Detailed medical records available prior to treatment (including chief complaint, history of present illness, radiological examinations, pathological examinations, laboratory tests, etc.).
Participants will receive complete treatment in the participating hospitals.

Exclusion

Participants with cancers other than gastrointestinal cancers.
Participants who receive treatment in multiple hospitals.

What this trial measures

  • Influence Rate of ChatGPT on Treatment PlansWithin 24 hours after the treatment plan is determined from the onset of study participation.

    The percentage of the initial 100 participants and the overall participants in the ChatGPT-Assisted group whose treatment plans are adjusted by clinicians after consulting with ChatGPT.